CJC-1295 vs Tesamorelin: What’s the Difference?
The main difference between CJC-1295 and Tesamorelin is mechanism: CJC-1295 is studied for sustained ghrh stimulation research — Short-acting GHRH analog. Tesamorelin is studied for visceral fat reduction research — Stabilized GHRH analog.
Broad GHRH analog vs visceral-fat-focused analog.
Key differences between CJC-1295 and Tesamorelin
- •Mechanism: CJC-1295 — Short-acting GHRH analog. Tesamorelin — Stabilized GHRH analog.
- •Primary research focus: CJC-1295 is studied for sustained ghrh stimulation research; Tesamorelin is studied for visceral fat reduction research.
- •Depth of human research: CJC-1295 — Moderate; Tesamorelin — Strong.
- •Typical study cadence cited in the literature: CJC-1295 — 2–3× daily — paired in same syringe with Ipamorelin; Tesamorelin — Daily, typically evening.
| Attribute | CJC-1295 GHRH analog | Tesamorelin Stabilized GHRH analog |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Sustained GHRH stimulation research | Visceral fat reduction research |
| Mechanism of action | Short-acting GHRH analog. Mimics natural pulsatile GH release. | Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat. |
| Human research | Moderate | Strong |
| Animal research | Moderate | Moderate |
| Mechanistic research | Established | Established |
| Study cadence cited | 2–3× daily — paired in same syringe with Ipamorelin | Daily, typically evening |
| In plain English | If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses. | Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically. |
| How it works | Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses. | Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue. |
| Researchers study | GH secretion, IGF-1 levels, body composition, and sleep architecture. | Visceral fat reduction, lipid metabolism, and cognitive function in older adults. |
| Internet discussion | DAC vs no-DAC is the eternal forum debate. | Discussed by people specifically targeting belly fat. |
Mechanism and research evidence, side by side
How CJC-1295 and Tesamorelin differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
CJC-1295
Short-acting GHRH analog. Mimics natural pulsatile GH release.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Mimics natural GH pulses; foundational stack with Ipamorelin
Tesamorelin
Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Strong
- Animal research
- Moderate
- Mechanistic research
- Established
Visceral fat reduction (particularly abdominal), GH/IGF-1 increase
CJC-1295
Sustained GHRH stimulation research
If ipamorelin opens the GH faucet, CJC-1295 widens the pipe. Together they produce larger natural GH pulses.
Activates the GHRH receptor in the pituitary, increasing the amplitude of natural GH pulses.
GH secretion, IGF-1 levels, body composition, and sleep architecture.
DAC vs no-DAC is the eternal forum debate.
CJC-1295 is a GHRH analog that amplifies natural GH pulses, especially when paired with a ghrelin mimetic.
Tesamorelin
Visceral fat reduction research
Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically.
Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue.
Visceral fat reduction, lipid metabolism, and cognitive function in older adults.
Discussed by people specifically targeting belly fat.
Tesamorelin is the GHRH analog with strongest data for reducing visceral fat specifically.